Sobi publishes report for the fourth quarter and full-year 2020
Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces its results for the fourth quarter and full-year 2020. Revenue growth for the full-year was 7 per cent with revenue of SEK 15,261 M. Adjusted EBITA was SEK 6,301 M, resulting in an adjusted EBITA margin of 41 per cent for the full year. October – December · Total revenue of SEK 4,581 M (4,890), -6 per cent (-2 per cent at CER) · Adjusted EBITA[1,2 ]was SEK 2,177 M (2,380), with an adjusted EBITA margin[1,2 ]of 48 per cent (49). Adjusted EBITA excludes positive impact from reversal of the CVR